ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "miR-146a-5p"

  • Abstract Number: 1246 • ACR Convergence 2021

    The Effect of Tocilizumab on miR-146a-5p and EMMPRIN/CD147 in Rheumatoid Arthritis Patients

    Devy Zisman1, Mirna Safieh1, Elina Simanovich1, Joy Feld2, Amalia Kinarty1, Liron Zisman1, Tal Gazitt3, Amir Haddad4, Muna Elias1, Itzhak Rosner5, Lisa Kaly6 and Michal A Rahat7, 1Carmel Medical Center, Haifa, Israel, 2Carmel and Zvulun Medical Centre, Haifa, Israel, 3Carmel Hospital, Haifa, Israel, 4Carmel Medical Centre, Haifa, Israel, 5Rheumatology Unit, Bnai Zion Medical Center, Haifa, Israel, 6Bnei Zion Medical Center, Haifa, Israel, 7Carmel Medical Center/Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel

    Background/Purpose: Angiogenesis is an important contributor to the development of rheumatoid arthritis (RA). Tocilizumab (TCZ), an anti-IL-6 receptor antibody used in the treatment of RA…

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology